Want to join the conversation?
$MAR's system-wide North America RevPAR grew 5% in Oct., roughly 4% in Nov. and just under 3% in Dec. The company believes it was the modest growth in GDP in 4Q15 that constrained its transient business, particularly premium-rated business. Houston system-wide RevPar fell 8% in the quarter reflecting weakness in the energy sector.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?